Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Med Chem
2001 Feb 01;443:340-9. doi: 10.1021/jm9904203.
Show Gene links
Show Anatomy links
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
Kim YC
,
Brown SG
,
Harden TK
,
Boyer JL
,
Dubyak G
,
King BF
,
Burnstock G
,
Jacobson KA
.
???displayArticle.abstract???
Novel analogues of the P2 receptor antagonist pyridoxal-5'-phosphate 6-azophenyl-2',5'-disulfonate (2) were synthesized and studied as antagonists in functional assays at recombinant rat P2X1, P2X2, and P2X3 receptors expressed in Xenopus oocytes (ion flux stimulation) and at turkey erythrocyte P2Y1 receptors (phospholipase C activation). Selected compounds were also evaluated as antagonists of ion flux and the opening of a large pore at the recombinant human P2X7 receptor. Modifications were made in the 4-aldehyde and 5'-phosphate groups of the pyridoxal moiety: i.e. a CH2OH group at the 4-position in pyridoxine was either condensed as a cyclic phosphate or phosphorylated separately to form a bisphosphate, which reduced potency at P2 receptors. 5-Methylphosphonate substitution, anticipated to increase stability to hydrolysis, preserved P2 receptor potency. At the 6-position, halo, carboxylate, sulfonate, and phosphonate variations made on the phenylazo ring modulated potency at P2 receptors. The p-carboxyphenylazo analogue, 4, of phosphate 2 displayed an IC50 value of 9 nM at recombinant P2X1 receptors and was 1300-, 16-, and > 10,000-fold selective for P2X1 versus P2X2, P2X3, and P2Y1 subtypes, respectively. The corresponding 5-methylphosphonate was equipotent at P2X1 receptors. The 5-methylphosphonate analogue containing a 6-[3,5-bis(methylphosphonate)]phenylazo moiety, 9, had IC50 values of 11 and 25 nM at recombinant P2X1 and P2X3 receptors, respectively. The analogue containing a phenylazo 4-phosphonate group, 11, was also very potent at both P2X1 and P2X3 receptors. However, the corresponding 2,5-disulfonate analogue, 10, was 28-fold selective for P2X1 versus P2X3 receptors. None of the analogues were more potent at P2X7 and P2Y1 receptors than 2, which acted in the micromolar range at these two subtypes.
???displayArticle.pubmedLink???
11462975
???displayArticle.pmcLink???PMC10790710 ???displayArticle.link???J Med Chem ???displayArticle.grants???[+]
Abbracchio,
Purinergic signalling: pathophysiological roles.
1998,
Pubmed
Alexander,
Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue.
1999,
Pubmed
,
Xenbase
Boyer,
Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
1994,
Pubmed
Brown,
Enhancement of the response to purinergic agonists in P2Y1 transfected 1321N1 cells by antagonists suramin and PPADS.
1997,
Pubmed
Buell,
An antagonist-insensitive P2X receptor expressed in epithelia and brain.
1996,
Pubmed
Burnstock,
Purinergic receptors: their role in nociception and primary afferent neurotransmission.
1996,
Pubmed
Camaioni,
Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors.
1998,
Pubmed
Charlton,
PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.
1996,
Pubmed
Chessell,
Cloning and functional characterisation of the mouse P2X7 receptor.
1998,
Pubmed
Collo,
Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.
1996,
Pubmed
Communi,
Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase.
1997,
Pubmed
Communi,
Receptors responsive to extracellular pyrimidine nucleotides.
1997,
Pubmed
Cook,
Distinct ATP receptors on pain-sensing and stretch-sensing neurons.
1997,
Pubmed
Damer,
NF279: a novel potent and selective antagonist of P2X receptor-mediated responses.
1998,
Pubmed
,
Xenbase
Fredholm,
Towards a revised nomenclature for P1 and P2 receptors.
1997,
Pubmed
Garcia-Guzman,
Molecular characterization and pharmacological properties of the human P2X3 purinoceptor.
1997,
Pubmed
,
Xenbase
Grubb,
Characterization of cultured dorsal root ganglion neuron P2X receptors.
1999,
Pubmed
Harden,
Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes.
1988,
Pubmed
Hoffmann,
Inhibition of Ecto-Apyrase and Ecto-ATPase by Pyridoxal Phosphate-Related Compounds.
2000,
Pubmed
Humphreys,
Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues.
1998,
Pubmed
Jacobson,
A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
1998,
Pubmed
,
Xenbase
Khakh,
Estimates of antagonist affinities at P2X purinoceptors in rat vas deferens.
1994,
Pubmed
Kim,
Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists.
1998,
Pubmed
,
Xenbase
King,
Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor.
1997,
Pubmed
,
Xenbase
King,
Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors.
1998,
Pubmed
Lambrecht,
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors.
2000,
Pubmed
,
Xenbase
Lambrecht,
PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.
1992,
Pubmed
Lewis,
Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons.
1995,
Pubmed
McLaren,
Investigation of the actions of PPADS, a novel P2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens.
1994,
Pubmed
North,
Nucleotide receptors.
1997,
Pubmed
Rae,
Pharmacological properties of P2X3-receptors present in neurones of the rat dorsal root ganglia.
1998,
Pubmed
Ralevic,
Receptors for purines and pyrimidines.
1998,
Pubmed
Soto,
Cloned ligand-gated channels activated by extracellular ATP (P2X receptors).
1997,
Pubmed
Townsend-Nicholson,
Molecular cloning, functional characterization and possible cooperativity between the murine P2X4 and P2X4a receptors.
1999,
Pubmed
,
Xenbase
Trezise,
The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
1994,
Pubmed
Windscheif,
Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptors.
1994,
Pubmed
Ziganshin,
PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder.
1993,
Pubmed
Ziganshin,
Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
1994,
Pubmed
Ziganshin,
Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevis.
1996,
Pubmed
,
Xenbase